GAD antibody-spectrum disorders (GAD-SDs) include a group of autoimmune neurological diseases associated with neuronal excitability, most noticeably stiff person syndrome (50%), cerebellar ataxia (43%), epilepsy (29%), and limbic encephalitis (16%) (1). This evidence concerns the gene GAD1 and aceruloplasminemia.